We ship Australia-wide with same-day dispatch on orders placed before 12pm AEST
One area of investigation involves the relationship between obesity, metabolic syndrome, and sexual dysfunction
Among adults with a BMI of 35 kg/m2 or greater, adults receiving enobosarm 3 mg plus semaglutide had a 5.58% weight loss at 16 weeks compared with a 4.7% weight reduction with semaglutide plus placebo
References: Matheson EM, et al
No randomized controlled trials have measured the combined effect of NAD plus tirzepatide on body composition, metabolic rate, or long-term weight retention
Starting at $45.00 10-vial kit save up to 25% SS-31 A mitochondria-targeted peptide studied in laboratory research involving mitochondrial membrane potential modeling, reactive oxygen species analysis, and cellular energy pathway investigation